Canada markets closed

Voyager Therapeutics, Inc. (VYGR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.440.00 (0.00%)
At close: 04:00PM EDT
8.08 -0.36 (-4.27%)
After hours: 07:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 459.04M
Enterprise Value 248.46M
Trailing P/E 2.84
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.50
Price/Book (mrq)1.94
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.98
52-Week Change 3-19.16%
S&P500 52-Week Change 326.43%
52 Week High 314.34
52 Week Low 36.06
50-Day Moving Average 38.83
200-Day Moving Average 38.18

Share Statistics

Avg Vol (3 month) 3670.69k
Avg Vol (10 day) 3478.6k
Shares Outstanding 554.39M
Implied Shares Outstanding 654.39M
Float 837.14M
% Held by Insiders 116.91%
% Held by Institutions 149.42%
Shares Short (Apr 15, 2024) 43.46M
Short Ratio (Apr 15, 2024) 44.08
Short % of Float (Apr 15, 2024) 47.60%
Short % of Shares Outstanding (Apr 15, 2024) 46.37%
Shares Short (prior month Mar 15, 2024) 42.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 52.93%
Operating Margin (ttm)60.03%

Management Effectiveness

Return on Assets (ttm)29.87%
Return on Equity (ttm)89.61%

Income Statement

Revenue (ttm)250.01M
Revenue Per Share (ttm)5.81
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 126.45M
Net Income Avi to Common (ttm)132.33M
Diluted EPS (ttm)2.97
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)230.88M
Total Cash Per Share (mrq)4.25
Total Debt (mrq)20.29M
Total Debt/Equity (mrq)8.59%
Current Ratio (mrq)4.96
Book Value Per Share (mrq)5.37

Cash Flow Statement

Operating Cash Flow (ttm)77.92M
Levered Free Cash Flow (ttm)-3.01M